Đang chuẩn bị liên kết để tải về tài liệu:
Cancer stem cell gene variants predict disease recurrence in patients treated with radical prostatectomy for prostate cancer

Đang chuẩn bị nút TẢI XUỐNG, xin hãy chờ

Cancer stem cells (CSCs) are involved in tumor progression and drug resistance. We hypothesized that variants in CSC marker genes influence treatment outcomes in prostate cancer. | Cancer stem cell gene variants predict disease recurrence in patients treated with radical prostatectomy for prostate cancer

TÀI LIỆU LIÊN QUAN

Association between cancer stem cell gene expression signatures and prognosis in head and neck squamous cell carcinoma

Cross platform analysis of methylation, miRNA and stem cell gene expression data in germ cell tumors highlights characteristic differences by tumor histology

Cancer stem cell gene variants predict disease recurrence in patients treated with radical prostatectomy for prostate cancer

Wilms’ tumor gene 1 is an independent prognostic factor for pediatric acute myeloid leukemia following allogeneic hematopoietic stem cell transplantation

Microenvironment dependent gene expression signatures in reprogrammed human colon normal and cancer cell lines

Tumour-associated glial host cells display a stem-like phenotype with a distinct gene expression profile and promote growth of GBM xenografts

An integrative gene expression signature analysis identifies CMS4 KRAS-mutated colorectal cancers sensitive to combined MEK and SRC targeted therapy

Meta-analysis of gene expression in relapsed childhood B-acute lymphoblastic leukemia

MAL gene overexpression as a marker of high-grade serous ovarian carcinoma stemlike cells that predicts chemoresistance and poor prognosis

RUNX1-Evi-1 fusion gene inhibited differentiation and apoptosis in myelopoiesis: An in vivo study